Summary by Moomoo AI
WuXi Biologics (Cayman) Inc. submitted a new next-day disclosure report on September 12, 2024, disclosing changes in its share structure. The report shows that the company issued 50,000 ordinary shares on September 12, 2024, as share incentives or options granted to participants, with an issue price of HKD 2.64 per share, accounting for 0.0012% of the total issued shares. In addition, WuXi Biologics conducted multiple share repurchases from June to September 2024, repurchasing a total of 33,335,000 shares at a repurchase price ranging from HKD 10.89 to HKD 11.65. All repurchased shares are intended to be canceled. The company confirmed that all share issuance and repurchase activities have been approved by the board of directors and comply with relevant listing rules and legal requirements. The last transaction of the repurchase activities was completed on September 12, 2024, repurchasing 4,805,000 shares on that day, with a total payment of HKD 55,999,180.
